India's Clinical Trials Market Accelerates - There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials. - BioPharm International

ADVERTISEMENT

India's Clinical Trials Market Accelerates
There has been a perceptible change from skepticism to acceptance in how India is viewed for clinical trials.


BioPharm International
Volume 21, Issue 5

REFERENCES

1. Anon. US wants FDA inspectors stationed in India. The Times of India. 2008; Mar 19. Available from: http://timesofindia.indiatimes.com/World/USA/US_wants_FDA_inspectors_stationed_in_India/articleshow/2880547.cms

2. Barnes K. FDA considering establishing Indian presence. Pharma Technologist. 2008. Available from: http://www.in-pharmatechnologist.com/news/ng.asp?n=82658-fda-india-china-inspection/

3. Leavitt M. Secretary Mike Leavitt's blog. Chennai, India. 2008; Jan 7. Available from: http://secretarysblog.hhs.gov/my_weblog/2008/01/chennai-india-w.html

4. Sahoo U, Kermani F. The contract research industry in India. In: Langer ES, editor. Advances in biopharmaceutical technology in India, 1st edition. Rockville, MD:BioPlan Associates, Inc. 2007. Available from: http://www.bioplanassociates.com/

5. Basu I. India's clinical trials and tribulations. The Asia Times. 2004. Available from: http://www.atimes.com/atimes/South_Asia/FG23Df03.html

6. Barnes K. What can CROs do to keep Indian clinical trials ethical? Pharma Technologist. 2006. Available from: http://www.in-pharmatechnologist.com/news/ng.asp?n=68154-chiltern-international-india-clinical-trial-cro/


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
Author Guidelines
Source: BioPharm International,
Click here